Author | Lightnews

Natera Genetics @natera.com · 7h

Proud to support the 4th Annual Gathering of the Wolves, hosted by Man Up To Cancer, an organization dedicated to supporting men with any kind of cancer diagnosis, providing community and resources to guide them through treatment and beyond. #Natera #ManUpToCancer
Man Up to Cancer

Natera Genetics @natera.com · 4d

Natera is honored to be a national sponsor of the Susan G. Komen More Than Pink Walk series. Together, we walk for hope, progress and a future without breast cancer. Thank you, Susan G. Komen, for welcoming us into this incredible community. 💗 #MoreThanPink #Natera
Susan G. Komen

Natera Genetics @natera.com · 4d

Natera has been named to @fastcompany.com’s 2025 Next Big Things in Tech list for Signatera™, our personalized MRD test that’s redefining how cancer is detected and managed. ow.ly/wFg050XblTy

#FCTechAwards #Natera

1

Reposted by Natera Genetics

NEJM.org @nejm.org · 5d

In muscle-invasive bladder cancer, ctDNA-guided atezolizumab led to longer disease-free survival (9.9 vs. 4.8 months), as well as to longer overall survival (32.8 vs. 21.1 months), than placebo among ctDNA-positive patients. Full IMvigor011 phase 3 trial results: nej.md/3WIRtEg

#ESMO25

Panel A: A graph of investigator-assessed disease-free survival among all patients with ctDNA-positive status who underwent randomization (primary end point).

Panel B: A graph of overall survival in the same population (secondary end point).

3 5

Natera Genetics @natera.com · 4d

We’re pleased to share a pivotal moment in MRD testing for Signatera™, with the New England Journal of Medicine publishing the results of IMvigor011. www.nejm.org/doi/full/10....

#ESMO25 #Natera

Natera Genetics @natera.com · 8d

Natera’s technology will be featured across multiple presentations at #ESMO2025. See the full schedule below and stop by booth #1016 to learn more. #Natera #MRD #Signatera
@myesmo.bsky.social

Natera Genetics @natera.com · 12d

Natera’s technology will be featured in 14 studies at the ESMO - European Society for Medical Oncology Congress, including 6 oral presentations. We look forward to connecting at #ESMO25 as we continue advancing personalized, MRD-guided cancer care for patients everywhere.

https://ow.ly/XJ1x50XaKc1

1 1

Natera Genetics @natera.com · 19d

We're honored to support the Bottoms Up Invitational by Colorectal Cancer Alliance. This event helps increase awareness for screening, fund research and support those affected by #ColorectalCancer. Learn more at: https://ow.ly/bOio50X3ZkJ
Photo credit: Andrew H. Walker/Shutterstock

1

Natera Genetics @natera.com · 21d

Join us as we celebrate survivors, thrivers & their families at the #SusanGKomen More Than Pink Walk series! #Natera is grateful and honored to be a part of the community.

💗 Miami, FL - 10/4
💗 San Francisco, CA - 10/5
💗 Oxand Hill, MD - 10/11
💗 Austin, TX - 10/26
💗 Los Angeles, CA -10/26

2

Natera Genetics @natera.com · 23d

Hello #NPWH2025 attendees!👋 Our team is thrilled to welcome you to booth #318 and share the latest innovations in maternal health and genetic testing.
#Natera #NPWH @npwh.bsky.social

1

Natera Genetics @natera.com · 24d

Andrea ‘Anj’ Oto knew that she had an increased risk of developing cancer due to her family history. Anj went in for her annual mammogram and her care team saw something suspicious that led to further testing — and a #breastcancer diagnosis. #Natera
Watch her story: https://ow.ly/XmZv50X4vhG

Anj’s Breast Cancer Story

ow.ly

1

Natera Genetics @natera.com · Sep 17

"Signatera gives me the power to go on with my life instead of constantly wondering ‘what-if.’"

Two days after a visit to the emergency room, Holly underwent surgery and received a rare ovarian cancer diagnosis.

www.natera.com/resource-lib...

#OvarianCancerAwareness #Signatera #MRDtesting #Natera

Meet Holly, Clear Cell Ovarian Cancer Survivor and Signatera Patient

Clear cell ovarian cancer can return—even years after treatment. #Signatera, Natera’s personalized MRD (ctDNA) test, looks for tiny traces of tumor DNA between scans and may detect molecular signs mon

www.natera.com

2

Natera Genetics @natera.com · Sep 15

Join our upcoming webinar w/ Katie Hashimoto, MS, CGC, Chris Sullivan, MD, FACOG & Dr. Shailen Shah, MD.

Review the latest advancements and unique capabilities of SNP-based NIPT and explore real-world case studies.

Register today: ow.ly/u9B650WX48I

Upcoming Webinar

NIPT Evolved: New insights, real cases, and better decisions

ow.ly

1

Natera Genetics @natera.com · Sep 5

Today is #TealDay for ovarian cancer awareness and Team #Natera dressed in teal to show their support! Our partner is National Ovarian Cancer Coalition, an incredible resource for statistics, support, and more to empower your healthcare journey. 💙💚

Learn more: ow.ly/ASPU50WSaIL

Natera Genetics @natera.com · Sep 2

Join this upcoming webinar with Dr. Midhun Malla and @dougfloramd.bsky.social as they discuss the role of #ctDNA testing for MRD assessment in #GICancer management.

🗓️ Sept 10 | 4 PM ET
Register today: ow.ly/nm3150WN6y5

#Natera

Natera Genetics @natera.com · Aug 28

Why test for genetic causes of kidney disease?
Genetic testing can reveal answers that may change the course of care for patients and their families.

Learn more about Renasight: ow.ly/gnm750WvvAj

#Natera #Renasight #KidneyHealth

1

Natera Genetics @natera.com · Aug 18

IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit

Read the full announcement here:
www.natera.com/company/news...

IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit

Topline results from the trial show that Signatera-positive patients treated with atezolizumab (Tecentriq®) had statistically significant and clinically meaningful improvements in disease-free surviva...

www.natera.com

2

Natera Genetics @natera.com · Aug 14

Did you know that it's common to be a carrier of a genetic condition, even w/out any noticeable symptoms or family history?🧬

🤰 Horizon Carrier Screening is a genetic test that can be done before or during pregnancy.

Learn more: ow.ly/qp7T50WfIU5
#Natera

Horizon Patient Information

ow.ly

Natera Genetics @natera.com · Aug 8

Learn more about the data presented: ow.ly/BhHn50WCeOa

#WTC2025 #Natera

Natera Highlights Latest Prospera™ Data at WTC 2025; 16 Abstracts Including Five Oral Presentations

High-impact datasets across heart, kidney and lung at WTC follows two major publications in the American Journal of Transplantation in the last three months AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc....

ow.ly

Natera Genetics @natera.com · Aug 8

Thank you for an incredible #WTC2025 & to our #Natera team for the success of:

🔬 16 abstracts in kidney, heart & lung
📊 The latest data on Prospera
🎤 Standing room only at our symposium with leading voices in transplant medicine

@astsconnect.bsky.social @astinfo.bsky.social @ttsorg.bsky.social

1 2

Natera Genetics @natera.com · Aug 4

Hello from #WTC2025 in SF👋Thank you to those who attended our exclusive lab tour! Stop by booth #1002 to learn more about the technology behind #Prospera and connect w/ our team.
RSVP here for our events ➡️ ow.ly/KoUj50Wz887
#Natera
@astsconnect.bsky.social @ttsorg.bsky.social @astinfo.bsky.social

1 2

Natera Genetics @natera.com · Aug 1

Meet us at booth #1002 to connect w/ our team and RSVP here ➡️ ow.ly/Hwwp50WyIwy for exclusive experiences:

• Behind-the-scenes lab tours at our Bay Area site
• A product theater in collaboration w/ @americankidneyfund.bsky.social

@astinfo.bsky.social @astsconnect.bsky.social @ttsorg.bsky.social

Natera at World Transplant Congress 2025

ow.ly

Natera Genetics @natera.com · Aug 1

See you soon at #WTC2025! We will have 16 abstracts spanning our organ health offerings in kidney, heart & lung including 5 oral presentations, showcasing several high-impact datasets.

Read more about our presentations here: ow.ly/cx1v50WyIwx

1 2

Natera Genetics @natera.com · Jul 29

Learn more about Signatera here: www.natera.com/oncology/sig...

Signatera for Bladder Cancer

Signatera™ monitors patients through ctDNA for bladder cancer and helps guide their treatments. Click here to learn more.

www.natera.com

Natera Genetics @natera.com · Jul 29

Adanma Ayanambakkam, MD, genitourinary oncologist at Stephenson Cancer Center shares recent data on the prognostic value of ctDNA-based MRD detection in patients with upper tract urothelial cancer.
#MRDTesting #Natera #Signatera

Watch the video: www.natera.com/resource-lib...

1